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Insulin induces a change in extracellular matrix glycoproteins synthe-
sized by rat mesangial cells in culture. Extracellular matrix (ECM)
accumulation within the glomerular mesangium is a hallmark of progres-
sive forms of renal disease. We recently succeeded in propagating
mesangial cells (MC) from the time of explant without supplemental
insulin which exhibit a matrix profile analogous to normal mesangium in
vivo. We used these cells to characterize insulin-induced changes in
biosynthesis and accumulation of three important matrix glycoproteins,
laminin, fibronectin, and thrombospondin. Two clones of MC derived
from glomeruli from a single rat were compared. MC grown in the absence
of supplemental insulin (SIMC) assemble a matrix rich in fibronectin
with much smaller accumulations of laminin and thrombospondin. In
comparison, MC (SIMC) grown chronically in the presence of 1 j.rM
insulin have a greatly expanded ECM that immunostains less intensely
with antibodies to fibronectin, but, it contains significant accumulations of
laminin and thrombospondin. Following metabolic labeling of secreted
proteins with 35S-methionine, total protein synthesis was measured, and
specific ECM components were identified and quantitated by immuno-
precipitation, SDS-PAGE and autoradiography. The rate of total protein
synthesis was increased by 50% in SIMC as compared to SIMC, yet,
individual proteins were increased or decreased. The rate of synthesis of
fibronectin was decreased and the rate of synthesis of laminin and
thrombospondin was increased by insulin. These changes were direction-
ally correlated with the net accumulation of these proteins as shown by
immunostaining. In addition to an increase in laminin synthesis, insulin
treatment induced a change in the isoform of laminin expressed. To
further delineate the role of insulin in the assembly of these different
matrices, MC chronically maintained without supplemental insulin were
exposed to 1 I.tM insulin. Morphologic and ECM compositional changes
occurred within 10 days. They were identical to those described for MC
propagated in supplemental insulin from the time of explant. Further-
more, insulin treatment of SF MC induced a prompt change in the
isoform of laminin synthesized. These results support our hypothesis that
insulin plays a direct role in modulating the composition of mesangial
matrix that accumulates in diabetic glomeruloscierosis.
This laboratory has been primarily interested in the pathogen-
esis of diabetic glomerulosclerosis, and factors relevant to the
diabetic milieu that may be responsible for the changes which
occur. Although insulin administration is essential to the manage-
ment of metabolic consequences of hyperglycemia, several studies
support the hypothesis that long term exposure to elevated levels
of insulin plays a direct role in the pathogenesis of diabetic
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nephropathy [1, 21. Insulin treatment of both normal rats and
those made diabetic with streptozotocin is associated with glomer-
ular hypertrophy and the new expression of collagen III within the
mesangial matrix [11. We recently reported that insulin treatment
causes mesangial cells (MC) to accumulate extracellular matrix
(ECM) rich in collagens I and III in place of collagen IV [2].Thus,
these studies provided the first in vitro evidence of a direct role for
insulin in regulation of the classes of collagen synthesized by MC
and established an in vitro model for studying diabetic nephrop-
athy.
In this study we sought additional evidence to support the
hypothesis that insulin treatment directly alters ECM production
by MC in culture. To this end, laminin (LM), fibronectin (FN),
and thrombospondin (TSP) synthesis, and their subsequent accu-
mulation within ECM were assessed in the presence and absence
of supplemental insulin. Each of these proteins are major struc-
tural components of the glomerular ECM [1], and they can exert
secondary effects on cellular proliferation, function, and cytokine
production [3]. Thus, insulin-induced alterations in their synthetic
rates, isoform expression, or degrees of accumulation could have
substantial pathogenic implications for the evolution of diabetic
nephropathy.
Methods
Cell culture
Rat glomerular mesangial cells were explanted, propagated and
characterized as described [4—8] with some modifications [2]. In
brief, glomeruli were isolated by sieving the renal cortex from a
single, male Sprague-Dawley rat and divided into two aliquots.
Glomeruli were plated in RPMI 1640 tissue culture medium
containing 20% fetal calf serum (FCS) and mixed 1:1 with
glomerular-conditioned medium [2]. MC, epithelial and endothe-
hal cell outgrowths were more abundant when glomeruli were
plated at high density; however, colonies from adjacent glomcruli
rapidly grew together, making it difficult to harvest pure cultures
of single cell types. We postulated that conditioned-medium
harvested from densely plated cultures might facilitate outgrowths
from sparsely plated glomeruli and thus would provide a practical
advantage. We presume growth factors are contained within this
conditioned medium, but they have not been assayed. Condi-
tioned medium was mixed 1:1 with standard medium only for the
initial plating of glomeruli and for the first feeding when colonies
were picked and transferred to separate plates. It was omitted
thereafter. The concentration of insulin in standard
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medium (RPM! 1640) containing 20% FCS is 0.8 to 1.0 X 10h1
M (provided by BioWhittaker, Walkersville, Maiyland, USA) and
the concentration of !GF-I was 4.5 to 5.5 X 10 M (assayed
using a kit from Nichols Institute, Irvine, California, USA). At the
time of initial plating one set had supplemental insulin added (1
MM) (SIMC), while the other did not (SIMC). MC cultures were
routinely fed two times per week. MC were selected from out-
growths, passaged, cloned and characterized as described [2].
Supplemental insulin (1 sM) is routinely added to culture medium
to facilitate cellular proliferation and aid in successful culture of
MC [6—8]. Yet, the ECM secreted by MC exposed to pharmaco-
logic concentrations of insulin in vitro [9, 10] mimics that which we
observed in insulin-treated animals [1]. Based on these findings,
we postulated that MC grown without supplemental insulin might
express a more normal ECM phenotype. The addition of glomer-
ular-conditioned medium in place of supplemental insulin allowed
successful outgrowth and cloning of SIMC. Unlike standard MC
that are routinely grown in supplemental insulin, SIMC secrete
and accumulate a collagen IV-rich ECM and demonstrate a
phenotype that is similar to MC in vivo [2]. For the present studies
cells were used at passages 4-5. The findings reported here were
performed on parent cultures, as well as cloned cells from each
parent culture. Identical changes have been observed on five
different occasions, and in subconfluent, confluent and long-term
cultures (4 weeks). To test the specific effects of insulin, insulin (1
MM) was added to SIMC with each feeding for 10 days. Cell
counts were performed using a model ZF Coulter counter
(Coulter Electronics, Miami, Florida, USA).
Analysis of extracellular matrix composition
SIMC and SIMC were grown for 21 days at which time the
cells had reached confluence, were growing in multilayers and
formed either multicellular nests (SIMC) or hillocks (S!MC) as
previously described [2]. The cells were scraped, pelleted, snap
frozen in isopentane and sectioned at 4 m for immunofluores-
cence microscopy [11]. This method allows analysis of the com-
position of the large collections of ECM that are evident in very
dense cultures, but, does not allow for high resolution observa-
tions of antigen distribution. To analyze the cellular content and
fine structural detail of antigen distribution in ECM, SIMC and
SIMC were plated in eight chamber slide flasks (Lab Tek, Nunc,
Inc., Naperville, Illinois, USA) and grown for four days in their
respective media. Cells were fixed with —20°C acetone and
methanol and stained for immunofluorescence microscopy. Stain-
ing was performed with commercially available fluorescein-conju-
gated, species-specific secondaiy antibodies to IgGs. Controls
included the appropriate non-immune IgGs for the primary
antibodies. Primary antibodies included rabbit anti-mouse EHS
sarcoma-derived laminin (Collaborative Research, Bedford, Mas-
sachusetts, USA) [1], rabbit anti-rat laminin (Chemicon, Te-
mecula, California, USA), rabbit anti-rat fibronectin [11, rabbit
anti-rat thrombospondin [12], and rabbit anti-rat glomerular
matrix [13]. Antibodies were prepared and characterized in our
laboratory [1] by Western blot and EL!SA. Each time the slides
were examined, they were coded and read without knowledge of
sample identity. Each were examined a minimum of three sepa-
rate occasions.
Biosynthetic labeling
SIMC and SIMC were plated in their respective standard
medium and allowed to proliferate for two days. To adjust for the
different growth rates of these two cultures, the number of cells
initially plated differed so that equal numbers were present at the
start of the labeling period (2 X 106 MC). Cell counts performed
on duplicate plates confirmed that cell numbers were equal at the
end of the experiment. Sixteen hours prior to harvest standard
medium was replaced with methionine deficient medium lacking
FCS and supplemented with 35S-methionine (50 MCi/mI). Me-
dium was harvested in 0.1 volume protease inhibitor cocktail
(0.025 M EDTA, 12.5 mg/mI NEM, 1.7 mg/mI PMSF, 0.02 mg/mI
pepstatin). Total secreted protein synthesis was assessed by
measuring trichloroacetic acid-precipitable radioactivity in the
medium. The profile of secreted proteins was studied by SDS-
PAGE [14]. Briefly, aliquots of medium samples containing equal
amounts of trichioroacetic acid-precipitable radioactivity were
subjected to SDS-PAGE (7% gels) under reducing conditions.
The gels were dried and placed in cassettes with Kodak X-Omat
film for radioautography [15]. Synthesis of specific glycoproteins
was assessed by radioimmunoprecipitation. Equal volumes of
culture medium and cell layers were pre-cleared by incubating
with Protein A Sepharose (Pharmacia, Piscataway, New Jersey,
USA). The appropriate antibody or corresponding non-immune
serum was added and incubated at room temperature for two
hours and then precipitated with the appropriate secondary
antibody and Protein A Sepharose beads as described [16]. The
precipitates were washed four times and boiled into Laemmli
buffer [14], run on SDS-PAGE under reducing conditions, dried
and exposed onto X-Omat film. The proteins were identified by
comparison to molecular weights markers and purified proteins.
Results
Effects of chronic exposure to insulin
Immunostaining of SIMC and SIMC cultures. The results of
immunostaining of MC cultures are shown in Figures 1 to 3.
Staining of cryostat sections represent confluent cultures where
cells were densely packed and grew in multiple layers and nests or
hillocks as described [2, 101. The ECM of both sets of MC
contained all three matrix glycoproteins examined (LM, FN,
TSP). Total surface area of ECM was shown by staining with a
polyspecific antibody to unfractionated glomerular matrix. The
total amount of matrix accumulated was markedly greater in
SPMC cultures as compared to those grown without supplemen-
tal insulin (Fig. 1). Despite the general increase in the amount of
matrix in SIMC cultures, the relative proportions of individual
matrix proteins differed. SIMC had small amounts of LM
detected in areas of ECM accumulation (Fig. 2). Scanty amounts
of TSP were detected in the assembled matrix around individual
cells. In contrast, there was intense staining for FN around and
over the entire surface of the cells. SLMC had significantly
greater amounts of LM and TSP detected in keeping with the
general increase in amount of matrix, yet the staining for FN was
significantly less. The data shown in Figures 1 and 2 are from
cryostat sections of MC clones from each parent culture, four
weeks after passage 4. Identical changes were observed in the
parent cultures from which the clones were derived, as well as
each of these types of MC as they reached confluence (data not
shown). Figure 3 depicts the staining pattern of cells plated in
LM
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Fig. 1. Immunofluorescence microscopy of SLMC (A) and SIMC (B) that have been stained with polyclonal antibody to unfractionated rat glomerular
matrix showing the total amount of ECM that accumulates in each of these cultures (original magnification 400 ><).
Fig. 2. Immunofluorescence microscopy of
clyostat sections of confluent cultures (21 days
after passage 4) of SIMC (A,C,E) and SIMC
(B,D,F) stained with antibodies to LM (A,B), FN
(C,D) and TSP (E,F) (original magnification 400
x).
chamber slides where cultures are subconfluent and have not yet
become multilayered. More cellular detail was apparent showing
evidence of intracellular synthesis of each of the proteins, as well
as deposition in the matrix adjacent to the cells, Directional
changes in the staining intensities of the matrix was the same for
each of the proteins as described above.
Short-term exposure to insulin
To assess the direct effect of insulin in mediating the changes in
the amount and composition of ECM proteins, SIMC were
maintained in their original medium or had insulin (1 /LM) added.
After seven additional days in culture, SIMC newly exposed to
insulin developed culture morphology and "hillocks" identical to
those propagated in insulin from the time of explant (data not
shown [2, 10]). The staining patterns of SPMC exposed to short-
term insulin are shown in Figure 4. Exposure of SIMC to insulin
induced a change in the amount of ECM, as well as the relative
proportions of LM, FN, and TSP as was demonstrated for
SIMC.
Biosynthetic labelling studies. The total amount of protein syn-
thesis was greater in SL1MC as compared to SIMC. With equal
cell numbers, SIMC incorporated 12.6 2.1% of counts into
I.
I
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Fig. 3. Immunofluorescence microscopy of cells
grown in chamber slides showing cellular and
ECM detail. SIMC (A,C,E) and SIMC
(B,D,F) were stained similarly to those shown
in Figure 2. LM (A,B), FN (C,D), and TSP
(E,F) (original magnification 400 x).
trichloroacetic acid precipitable proteins, whereas SIMC incor-
porated 20.6 2.2% of counts into synthesized protein (ANOVA,
P < 0.01). When equal counts of radiolabeled proteins were
loaded onto the gel, they gave distinctive and different patterns of
protein synthesis as shown in Figure 5. To determine whether the
changes in accumulation of various proteins in the ECM as
described above were due to changes in rates of synthesis of
individual proteins, radioimmunoprecipitation experiments were
performed. The results are shown in Figure 6. FN synthesis was
significantly greater in SIMC as compared to SIMC, indicating
that the increased FN accumulation in these cultures was in part
due to a higher rate of synthesis of this glycoprotein. These data
showed that insulin decreases the relative rate of FN synthesis.
The immunoprecipitates of TSP indicated that insulin treatment
of MC cultures similarly increased the rate of TSP synthesis. The
intensity of bands for LM is similarly greater in the immunopre-
cipitates from SPMC cultures as compared to those grown
without supplemental insulin. SIMC express LM A, Bi, and B2
chains, with greater amounts of Bi and B2 relative to A chain.
Compared to SIMC, SIMC secrete less A, Bi and B2 chains.
Interestingly, and in contrast to SPMC, SLMC secrete a novel
LM chain that migrates between A and Bi on SDS-PAGE. Thus,
in the absence of supplemental insulin MC secreted an alternative
LM isoform. With chronic insulin treatment of cultures, expres-
sion of this novel LM chain was inhibited, while expression of
other LM chains and total immunoprecipitable LM was increased.
Short-term (2 days) treatment of SLMC with insulin caused
similar changes in the isoform of LM, as shown in Figure 7. In
summary, insulin treatment of SLMC caused decreased synthesis
of FN, increased synthesis of TSP, and both a quantitative
increase in LM synthesis and a qualitative change in the chain
composition of LM.
Discussion
The present study demonstrates that insulin treatment of MC in
culture induces dramatic changes in the synthesis and net accu-
mulation of LM, FN and TSP. The immunostaining of cryostat
sections of confluent cultures reflects accumulation of ECM
proteins that is the net result of changes in synthesis, assembly of
secreted proteins into the ECM and changes in degradation.
Short-term biosynthetic labeling experiments are usually consid-
ered to reflect rates of new protein synthesis. These results
directionally correlated with the amount of protein accumulated
in the ECM and the intensity of intracellular staining. Thus,
changes in synthesis in part account for the changes in net
accumulation within the ECM. Degradation rates and mecha-
nisms of assembly were not measured; however, these may also
play important roles in the accumulation of ECM. Moreover,
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Fig. 4. Immunofluorescence microscopy of
SIMC prior to (A,C,E) and following short term
(7 days) exposure to I p insulin (B,D,F). Slides
were stained for LM (A,B), FN (C,D) and TSP
(E,F) (original magnification 400 x).
insulin treatment is associated with a change in the isoform of LM
that is secreted. These differences were demonstrated by compar-
ing the ECM composition of cultures propagated in insulin from
the time of explant, as is routinely done in most studies of MC, to
the ECM composition of MC propagated continuously without
supplemental insulin. Furthermore, short-term insulin treatment
of SIMC induced the same changes in pattern of ECM secretion
and accumulation. This result confirmed that these changes are
due to insulin rather than the result of having selected clones
expressing unique phenotypes. Similar changes in ECM synthesis
and accumulation were observed in subconfluent, confluent and
long-term cultures, suggesting that these observations were not
simply the result of cell density. Since these studies were per-
formed, we prepared two clones from another rat that express the
same growth pattern and ECM composition as reported here,
strengthening our argument that the results are not due to
random selection of cells with a peculiar phenotype. These data,
as well as our previous studies of collagen [2], demonstrate that
the final MC ECM that accumulates under the influence of
supplemental insulin differs in total amount of ECM, relative
content of the major ECM components, as well as alterations in
the collagen types and isoform of LM.
Diabetic glomerulosclerosis is characterized by fractional ex-
pansion of mesangial matrix which ultimately occludes glomerular
capillary lumena with consequent loss of renal function [17]. The
complex metabolic environment of diabetes provides a number of
candidate hormones, growth factors, and metabolic factors which
may contribute to the pathogenesis of mesangial matrix accumu-
lation. Insulin is essential to the management of hyperglycemia,
yet recent evidence suggests that there are also adverse conse-
quences of hyperinsulinemia [18—21]. Given our in vivo data [1]
which demonstrate that insulinperse can contribute to glomerular
hypertrophy and mesangial matrix accumulation in diabetic ne-
phropathy, we have postulated that periods of hyperinsulinemia,
in addition to hyperglycemia, contribute to the development of
mesangial matrix expansion.
Previous studies have demonstrated that SIMC express recep-
tors for IGF-I, but not insulin [4, 22, 23J. It has been presumed
that tM concentrations of insulin act via binding to the IGF-I
receptor. In recent studies we have shown that SIMC express
insulin receptors' have a greater proliferative response to low
concentrations of insulin than do SPMC, and that changes in the
amount and profile of collagen synthesized can be induced with
insulin, but not IGF-I [2]. Since the previous studies were
completed, we have added 1 n insulin to SIMC. Although
changes in collagen profile take longer to develop in 1 nM insulin
than they do with 1 jM insulin, new accumulation of interstitial
collagens become detectable after three to four weeks. Studies of
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Fig. S. Biosynthetic labeling experiments showing profi les of labeled proteins
for SIMC (left lane) and SIMC (right lane). Trichtoroacetie acid
precipitated proteins were subjected to SDS-PAGE under reducing
conditions. Molecular weight markers (kDa) are shown at the left. Note
the change in profile of proteins synthesized by SLMC and SIMC
cultures.
the specific effects of IGF-I on synthesis of ECM glyeoproteins by
SIMC need to be performed.
FN is a large multidomain, multifunctional glycoprotein that
mediates cell attachment, migration, maintenance of cellular
phenotype and ECM assembly [24]. In the MC system, FN
promotes cell elongation and proliferation [251, is chemotactie
[26], and promotes prostaglandin release [27]. In the context of
diabetes mellitus, advanced glycosylation end product (AGE)-
modified matrix increases the rate of FN synthesis by MC [28]
through a specific AGE-receptor mechanism with PDGF as an
intermediate messenger [29]. Glucose treatment of MC increases
FN protein and mRNA through a protein kinase C-mediated
mechanism [16, 30—33]. The in vitro studies are complemented by
in vivo data which show increased amounts of FN in early lesions
of diabetic nephropathy [1, 34—36]. Our data exclude a major
direct effect of insulin on the mechanism for FN synthesis in
diabetic nephropathy, making it likely that FN accumulation in
diabetic nephropathy is predominantly mediated by hypergly-
cemia.
The TSPs are members of a family of large, multidomain,
extracellular adhesion molecules with a number of biological
activities relevant to the kidney, including modulation of the
response of cells to growth factors, cell attachment and migration
[37, 38] and angiogenesis [39]. TSP is present in normal renal
tissue [40], present in increased amounts in glomeruli of insulin-
treated normal and streptozotocin diabetic rats [1] and is secreted
and incorporated into ECM of MC [41, 42]. Our results are
consistent with the hypothesis that insulin treatment modulates
TSP synthesis in MC and is relevant to the increase in TSP
accumulation in diabetic nephropathy [1]. Given recent observa-
tions that demonstrate interactions of TSP and FN in angiogenic-
anti-angiogenie activities [38, 39, 43], effects of insulin on these
two important glycoproteins may have significant consequences
on glomerular function, as well as proliferative diabetic retinop-
athy.
In addition to FN and TSP, LM is abundant within the
mesangium [1], its synthesis is increased by glucose [16] and it
accumulates in diabetic glomerulosclerosis [30]. The present
studies demonstrate that insulin can also increase the rate of
synthesis of LM, its accumulation within the ECM, and alter the
isoform of LM synthesized. These observations have important
implications for LM-mediated cell-matrix interactions. LM de-
rived from EHS sarcoma is a heterotrimeric molecule that
contains equimolar amounts of Ae, Ble, and B2e chains, but it is
one member of a family of tissue and cell-specific LMs [44]. For
example, many cells in culture, including SIMC synthesize a LM
that is relatively deficient in A chain [45, 46]. A similar molecule
has been described in rat liver epithelial cells [47]. Rotary
shadowing studies demonstrate that it has a Y shape [44, 48]
rather than the cruciform appearance of AB1B2 [24]. Substitution
of the A chain with truncated and other A chain homologues has
been postulated to be physiologically important. Many effects of
LM on cell function have been attributed to the A chain, some of
which have been mapped to specific peptide sequences [49]. A
chain distribution plays a key role in renal development [50] and
dictates polarization of renal tubular epithelium [51]. Individual
peptides within A chain, as well as the Bi chain, facilitate or
inhibit angiogenic activity of endothelial cells [52]. Glomerular
basement membrane contains LM in which the Bi chain has been
replaced with sLM (designated Bis) [53]. Mesangial matrix
appears to express an alternative splice product of sLM, as it binds
some, but not all of the monoclonal antibodies to sLM [46,
unpublished observations]. Changes in Bi composition serve as a
stop signal for neurite outgrowth [54], and influence assembly of
the heterotrimer [55, 56] and its assembly into mature ECM [56,
57]. In the absence of supplemental insulin, a separate protein
band of approximately 280 kD was immunoprecipitated along
with proteins that co-migrate with Ae, Ble and B2e chains. LM
with similar properties has been described by Tokida et at [58] in
endothelial cultures treated with angiostatic steroids. In that
study, this chain was designated A', although to date it has not
been sequenced. For consistency we have similarly designated this
undefined protein band A'. It is possible that this is a protein
synthesized by SLMC that co-precipitates with LM, but like
entactin which is bound to LM, it is not a LM-related protein. In
preliminary studies we have shown by Western blot that this band
binds antibody raised to an A chain peptide. For this reason we
believe that A' is a LM-related protein. We are currently con-
ducting experiments to clone and sequence this novel LM chain to
confirm that it is a LM A chain family member. Given important
studies which show that the isoform of LM expressed is critical to
cell proliferation, differentiation, and response to a variety of
other cell mediators, it is likely that insulin-mediated changes in
LM are equally or more important than are simple changes in the
rate of matrix synthesis.
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Fig. 6. Radioimmunoprecipitation of labeled
proteins from culture medium showing LM, FN
and TSP synthesis by SIMC and SIMC.
Imrnunoprecipitated proteins were subjected to
SDS-PAGE (7%) under reducing conditions
followed by autoradiography. Relative
molecular weights (kDa) are shown on the
right. The appropriate bands are identified: LM
chains A, A', B1, B2 and entactin (ENT) which
co-precipitates with LM; FN and TSP.
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